Qms Medical Allied Services Q2 FY27 earnings call: Q2 FY27 revenue grew 17.5% year-on-year to INR52.5 crores with a 12.4% EBITDA margin, while H1...
Results · 17 Nov 2026 · Qms Medical Allied Services (QMSMEDI)
| Q2 FY27 | ₹ Cr |
|---|---|
| Revenue | 53 |
| Net profit | 6 |
Q2 FY27 revenue grew 17.5% year-on-year to INR52.5 crores with a 12.4% EBITDA margin, while H1 FY27 revenue rose 20% to INR109.4 crores and PAT stood at INR6.4 crores.
Management expects full-year standalone FY27 revenue of INR210 crores to INR220 crores, while deferring full-year EBITDA guidance for one more quarter after Q2 product margin hits.
QMS acquired the remaining 24% of Saarathi Healthcare and approved merging HCAH's patient support program unit into it, targeting INR180 crores combined FY27 revenue and 20% to 25% CAGR.
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.